Targeting cell cycle machinery as a molecular mechanism of sulforaphane in prostate cancer prevention

Longgui Wang1, Delong Liu, Tauseef Ahmed

  • 1Division of Medical Oncology, Mount Sinai Medical Center, New York, NY 10029, USA.

Insights

Sulforaphane (SFN), a compound in cruciferous vegetables, inhibits prostate cancer cell growth and tumorigenesis. It works by arresting the cell cycle and inducing apoptosis in cancer cells.

Area of Science:

  • Oncology
  • Nutritional Biochemistry
  • Molecular Biology

Background:

  • Epidemiological studies link cruciferous vegetable consumption to reduced prostate cancer risk.
  • The specific phytochemicals and mechanisms responsible for this protective effect remain largely unknown.
  • Prostate cancer can become androgen-independent, necessitating research into alternative prevention strategies.

Purpose of the Study:

  • To investigate the effects of sulforaphane (SFN) on androgen-independent prostate cancer cell growth and tumorigenesis.
  • To elucidate the molecular mechanisms by which SFN influences prostate cancer cell proliferation and survival.

Main Methods:

  • Exposure of human androgen-independent DU-145 prostate cancer cells to SFN.
  • Assessment of cell density, DNA synthesis, and clonogenesis to evaluate growth inhibition.
  • Analysis of cell cycle regulators, including cyclin-dependent kinases (CDKs), CDK inhibitors, and Bcl-2.
  • Measurement of caspase activation to confirm apoptosis induction.

Main Results:

  • SFN significantly inhibited the growth and tumorigenesis of DU-145 prostate cancer cells.
  • SFN induced cell cycle arrest at the G1 to S-phase transition by down-regulating cyclin D1 and CDK4 activity, and up-regulating p21WAF-1/Cip-1.
  • SFN promoted apoptosis by down-regulating the anti-apoptotic protein Bcl-2 and activating caspases.

Conclusions:

  • Sulforaphane effectively inhibits the proliferation and induces apoptosis in androgen-independent prostate cancer cells.
  • Cell cycle regulators and apoptosis pathways are key targets of SFN's anti-cancer activity.
  • SFN shows potential as a dietary factor for preventing prostate cancer initiation and progression.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...